Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes

July 2010

Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes in Canada....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Gastroenterology limit use of PPIs (omeprazole, etc)
Respiratory & Allergy whether it's okay to give beta-blockers to patients with chronic obstructive pulmonary disease (COPD)
Respiratory & Allergy alerts for interactions between salmeterol and strong CYP3A4 inhibitors...clarithromycin, itraconazole, ritonavir, etc
what lab tests are needed for certain drugs
Diabetes Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes
Diabetes which diabetes patients should take aspirin
Vitamins & Minerals how much vitamin D is too much
Smoking Cessation more changes to Champix labelling
Gastroenterology mix-ups between Maalox products
Neurology & Pain more concern about tramadol abuse and suicide
genetic tests marketed to consumers
Bites & Stings What really works to repel mosquitoes, ticks, and other insects
Men's Health controversy about using testosterone in older men